New research showed that low-dose peanut oral immunotherapy safely raised reaction thresholds in children with peanut allergy ...

Researchers in England have found that roughly 80 percent of children with peanut allergies who participated in an experimental treatment were able to build resistance to the allergy and can now ...

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection against ...

It’s possible to develop a peanut allergy later in your life. According to a 2021 study, approximately 17.5% of people with peanut allergies developed the allergy as adults. Adult-onset peanut ...

Allergies are becoming more prevalent in the US, affecting over 100 million individuals. Common allergies include eczema, ...

Peanut allergy is one of the most common food allergies, affecting between 1% and 2% of people living in the west. And, for many years, their prevalence has been rising. But a recent study out of the ...

Some good news on the health front: Peanut allergies are on the decline. A new study, published on Oct. 20, shows we may be on the way to eliminating the peanut allergies that have been problematic ‒ ...

More peanut-allergic children receiving a 30 mg maintenance dose for peanut oral immunotherapy vs. avoiding peanut tolerated at least 443 mg and 1,043 mg of peanut protein at 1 year, according to ...

Nearly 70% of children with low-risk peanut allergy tolerated a peanut oral food challenge, negating the need for allergy treatment, data from one center showed. Researchers sought to determine how ...

After parents were advised to introduce children at risk of nut allergies to peanuts, the number of allergic kids dropped by more than 40% Getty The number of children with food allergies — ...